Garret Hampton, Phd
Executive Vice President, Clinical Genomics
United States of America
Garret Hampton joined Illumina in 2017 and leads the company’s Clinical Genomics Group, which includes the Reproductive and Genetic Health and Oncology Businesses, Regulatory, Clinical and Medical Affairs, CLIA Labs, and the Chief Medical Officer’s organization. Before joining Illumina, he held a variety of leadership positions at Genentech, Inc., and was most recently Vice President and Global Head of Oncology Biomarker Development and Companion Diagnostics. He previously held scientific and management roles at Celgene Corporation, Genomics Institute of the Novartis Research Foundation, and Genos Biosciences. Hampton holds a BA in natural sciences and genetics and an MA in natural sciences from Trinity College in Dublin, Ireland, and a PhD in cancer genetics from Imperial Cancer Research Fund and University College London.